Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-02 Sale | 2023-06-02 7:15 pm | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie Chief Financial Officer | 4,647 | $37.06 | $172,218 | 80,015 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 4:44 pm | N/A 2034-06-05 | PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director | 67,500 | $0 | 67,500 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 4:10 pm | N/A 2034-05-14 | Spyre Therapeutics Inc. | SYRE | Stelzer Laurie Director | 11,323 | $0 | 11,323 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-27 4:33 pm | N/A 2033-11-22 | Spyre Therapeutics Inc. | AGLE | Stelzer Laurie Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-10 4:26 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie Chief Financial Officer | 22,297 | $37 | 102,312 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 5:55 pm | N/A 2033-06-07 | PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director | 21,500 | $0 | 21,500 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO | 72,320 | $0 | 130,118 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 8:00 pm | N/A 2032-06-08 | Surface Oncology Inc. | SURF | Stelzer Laurie Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:59 pm | N/A 2032-06-01 | PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director | 19,500 | $0 | 19,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 5:56 pm | N/A 2032-05-31 | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO | 148,962 | $0 | 148,962 (Direct) | View |
Ownership | 2022-05-16 5:01 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO | 0 | $0 | 0 (Direct) | View |
| 2022-03-11 Other | 2022-03-11 4:12 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer | 37,208 | $0 | 37,208 (Direct) | View |
| 2022-03-11 Disposition | 2022-03-11 4:12 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer | 186,050 | $0 | 37,208 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 5:00 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer | 21,462 | $0 | 36,366 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 4:30 pm | N/A 2031-06-08 | Surface Oncology Inc. | SURF | Stelzer Laurie Director | 17,700 | $0 | 17,700 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-09 5:39 pm | N/A 2031-06-01 | PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director | 16,333 | $0 | 16,333 (Direct) | View |
| 2021-03-16 Tax Withholding | 2021-04-02 8:10 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer | 4,356 | $76.1 | 14,904 (Direct) | View |
| 2021-03-16 Exercise | 2021-04-02 8:10 pm | N/A 2022-01-03 | ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer | 12,600 | $0 | 14,904 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:33 pm | N/A 2028-03-01 | ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer | 60,710 | $0 | 60,710 (Direct) | View |
Ownership | 2020-09-24 7:21 pm | N/A 2030-08-11 | PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director | 0 | $0 | 32,667 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | Stelzer Laurie Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-03-16 Option Award | 2020-03-17 6:47 pm | N/A 2027-03-16 | ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer | 138,300 | $0 | 138,300 (Direct) | View |
| 2020-02-22 Tax Withholding | 2020-02-24 8:03 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 4,508 | $21.83 | 137,559 (Direct) | View |
| 2020-02-22 Exercise | 2020-02-24 8:03 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 11,392 | $0 | 137,559 (Direct) | View |
| 2020-02-14 Tax Withholding | 2020-02-18 4:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 2,700 | $21.1 | 134,899 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-18 4:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 7,809 | $0 | 134,899 (Direct) | View |
| 2020-02-12 Tax Withholding | 2020-02-13 6:38 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 3,894 | $20 | 114,174 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-13 6:38 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 11,262 | $0 | 114,174 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:59 pm | 2021-02-10 2030-02-10 | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 101,707 | $0 | 101,707 (Direct) | View |
| 2020-02-03 Tax Withholding | 2020-02-04 4:21 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 8,275 | $19.21 | 106,806 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 4:21 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Stelzer Laurie SVP, Chief Financial Officer | 23,119 | $0 | 106,806 (Direct) | View |